Q4 2025 SBC Medical Group Holdings Inc Earnings Call Transcript
Key Points
- SBC Medical Group Holdings Inc (SBC) achieved a 2% year-over-year growth in total clinic revenue, reaching $1,163 million.
- Average revenue per customer rebounded significantly in the fourth quarter, increasing by 11% year-over-year to $316.
- Net income attributable to shareholders grew by 9% year-over-year to $51 million, with EPS increasing by 4% to $0.50.
- SBC maintained a strong EBITDA margin of 40.4%, indicating robust profitability.
- The company is strategically expanding its global presence with investments in the United States and partnerships in Thailand.
- Full-year revenue decreased by 15% from the prior year, primarily due to business restructuring and fee structure changes.
- Same-store sales were slightly below the prior year, indicating challenges in maintaining consistent growth across existing locations.
- The company is still in the early stages of international expansion, which may pose risks and uncertainties.
- The impact of structural transitions on revenue highlights potential volatility in financial performance.
- SBC's strategy involves significant investments in AI and global expansion, which could strain resources and require careful execution.
Good day, everyone, and thank you for joining SBC Medical Group Holdings Conference Call. My name is Yoshiyuki Aikawa, CEO of SBC Medical Group Holdings. Today, I will walk you through our performance for the fourth quarter and full year of fiscal 2025, followed by an update on our business strategy and capital policy.
Let me begin with highlights from our clinic operations. As of the end of December 2025, we were operating 283 locations, and the number of customers served over the trailing 12 months reached 6.63 million. While same-store sales were slightly below the prior year, total clinic revenue for the full year reached $1,163 million, representing 2% year-over-year growth.
Most encouragingly, average revenue per customer, which had been on a declining trend, rebounded significantly in the fourth quarter, reaching $316, an 11% increase year-over-year. We are now seeing both customer growth and improving unit economics moving in the same direction, which we view as a meaningful
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
